Twist Bioscience TWST 深 沪
交易中 05-19 09:47:44 美东时间
48.52
-1.270
-2.55%
华盛通- 最 高49.29
- 今 开49.29
- 成交量 1.41万股
- 最 低 48.52
- 昨 收 49.79
- 总市值 30.21亿
- 52周最高 66.06
- 市盈率 静 --
- 换手率 0.02%
- 52周最低 23.30
- 委 比 -29.03%
- 总股本 6227.13万
- 历史最高 214.07
- 量 比 2.03
- 振 幅 1.55%
- 历史最低 11.46
- 每 手 1
- 风险率 9.90%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股夜盘 | 阿吉赛斯涨14.10%，Penguin Solutions Incorporation涨4.31%
阿吉赛斯涨14.10%；Penguin Solutions Incorporation涨4.31%；T1 Energy涨3.86%
今天 09:01
Cathie Wood’s weekly update: buys Cerebras, Tempus AI, sells AMD and TSM
Cathie Wood’s ARK Invest ETFs increased exposure to AI infrastructure, genomic medicine, fintech, and defense tech during the last week, while trimming semiconductor, genomics, and space-related holdi...
05-18 18:50
美股大行评级 | Stifel上调Lumentum控股目标价从800美元升至1100美元；Pinterest、先进能源工业、安森美半导体、莱迪思半导体、V2X等获多家大行上调目标价
今日重点评级关注：Piper Sandler：维持Aclaris Therapeutics"超配"评级，目标价从7美元升至11美元；Evercore ISI集团：维持BioMarin Pharmaceutical"跑赢大市"评级，目标价从110美元升至120美元
05-06 11:29
Baird Maintains Outperform on Twist Bioscience, Raises Price Target to $65
Baird analyst Catherine Ramsey maintains Twist Bioscience (NASDAQ:TWST) with a Outperform and raises the price target from $50 to $65.
05-05 20:04
U.S. RESEARCH ROUNDUP- Applied Materials, Axsome Therapeutics, Onsemi
U.S. RESEARCH ROUNDUP- Applied Materials, Axsome Therapeutics, Onsemi May 5 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Applied Materials, Axsome Therapeutics and Onsemi on Tuesday. HIGHLIGHTS * Applied Materials AMA
05-05 15:07
财报速睇 | Twist Bioscience 2026财年Q1营收1.11亿美元，同比增长19.3%；归母净利润亏损0.44亿美元，同比亏损扩大11.9%
华盛资讯5月5日讯，Twist Bioscience公布2026财年Q1业绩，公司Q1营收1.11亿美元，同比增长19.3%，归母净利润亏损0.44亿美元，同比亏损扩大11.9%。
05-05 12:32
AI-Driven Demand Boosts Twist Bioscience Sales, But Loss Widens
Twist Bioscience posts wider Q2 loss, beats revenue estimates, raises FY26 outlook, and expands gene portfolio.
05-05 01:46
Twist Bioscience Q2 2026 Earnings Call Transcript
Twist Bioscience (NASDAQ:TWST) released second-quarter financial results and ho...
05-04 21:11
财报速睇 | Twist Bioscience 2026财年Q1营收1.11亿美元，同比增长19.3%；归母净利润亏损0.44亿美元，同比亏损扩大11.9%
华盛资讯5月4日讯，Twist Bioscience公布2026财年Q1业绩，公司Q1营收1.11亿美元，同比增长19.3%，归母净利润亏损0.44亿美元，同比亏损扩大11.9%。
05-04 19:32
Twist Bioscience Q2 Adj. EPS $(0.59) Misses $(0.48) Estimate, Sales $110.715M Beat $107.657M Estimate
Twist Bioscience (NASDAQ:TWST) reported quarterly losses of $(0.59) per share which missed the analyst consensus estimate of $(0.48) by 22.92 percent. This is a 10.61 percent increase over losses of $(0.66) per share
05-04 19:25
